Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gavin Shepherd Insider Profile
4 Followers
Gavin Shepherd, Director at Prescient Therapeutics Limited, holds 16.39M shares in Prescient Therapeutics Limited (Ticker: AU:PTX). Most recently, Gavin Shepherd Bought AU$235,908 shares of Prescient Therapeutics Limited on Oct 03, 2024 for an estimated value of 9.44K.
Gavin Shepherd has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Director
Roles that Gavin Shepherd holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Gavin Shepherd
Gavin Shepherd's Trading History
List of latest transactions for each holding click on a transaction to see Gavin Shepherd's performance on stock
You May Also Like
Gavin Shepherd insider profile FAQ
What is the percentage of profitable transactions made by Gavin Shepherd?
The percentage of profitable transactions made by Gavin Shepherd is ―.
What is the average return per transaction made by Gavin Shepherd?
The average return per transaction made by Gavin Shepherd is ―.
What stocks does Gavin Shepherd hold?
Gavin Shepherd holds: AU:PTX stocks.
What was Gavin Shepherd’s latest transaction?
Gavin Shepherd latest transaction was an Informative Buy of AU$9.44K.
What was Gavin Shepherd's most profitable transaction?
Gavin Shepherd’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Gavin Shepherd's role in Prescient Therapeutics Limited?
Gavin Shepherd's role in Prescient Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.